Investor
The consumer genetics company reported full-year revenue came to $272 million, an 11% increase compared with the prior year.
Also: Komodo Health appoints Dr. Aswin Chandrakantan chief operating officer in addition to his role as chief medical officer.
The London-based company most recently raised £5 million in Series A funding in 2020.
The company develops a breakthrough device for detecting residual cancer tissues.
The company launched in December with a $2.8 million seed.
The company seeks to grow its network of pharmacies across the region.
The company provides resources and care navigation for people who are assisting older family members or loved ones with disabilities.
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
The startup, which offers remote assessments for conditions like ADHD and dyslexia, emerged from stealth Friday with a total of $4.2 million in funding.
The startup launched in August last year with a $3.2 million seed.